The 11-mer peptide allowed for the stimulation of CD4+ T cells, that have been shown, in addition to providing help to CD8+ CTLs, to mediate potent anti-tumor, HLA class II-mediated, cytotoxic responses in vivo [27]. The gene discussed is CD8A; the disease is neoplasm.